Task: Answer the multiple-choice question.
Query: Which drug exhibits a -16.532% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
(a) CCCc1nc2nc(C)c(NS(=O)(=O)c3ccc([N+](=O)[O-])cc3)c(=O)n2[nH]1
(b) COc1ccc(CCNC(=O)CSc2nn(-c3ccccc3)c(=S)s2)cc1OC
(c) Cc1cccc(/C=N/NC(=O)c2cccc(NC(=O)c3ccccc3)c2)n1
(d) [O-][n+]1onc2c1CCc1[nH]c(-c3ccccc3)nc1-2
(e) CCOC(=O)c1c(C=O)c2ccccc2n1Cc1ccccc1
Answer: b. COc1ccc(CCNC(=O)CSc2nn(-c3ccccc3)c(=S)s2)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(CCNC(=O)CSc2nn(-c3ccccc3)c(=S)s2)cc1OC
COc1ccc(CCNC(=O)CSc2nn(-c3ccccc3)c(=S)s2)cc1OC
N-[2-(3,4-dimethoxyphenyl)ethyl]-2-[(4-phenyl-5-sulfanylidene-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide